Interactions of CNS Drugs Psychotherapeutic Agents — Antidepressants

Anon: FDA Adverse Reaction File # 700301-195-00101. (CH).

Anon: Estrogen May Well Affect Response to Antidepressant, J. Amer. Med. Assoc. 219: 143 (Jan. 10) 1972. (Report).

Anon: Today's Drugs: Monoamine Oxidase Inhibitors, Brit. Med. J. 2: 35 (Apr. 6) 1969. (R).

Anon: Analgesics and Monoamine-Oxidase Inhibitors (Any Questions) Brit. Med. J. 4: 284 (Nov. 4) 1967. (R).

Abdou F. A. : Elavil-Librium Combination, Am. J. Psychiat. 120: 1204 (June) 1966. (CH).

Aderhold R. M. Muniz C. E. : Acute Psychosis with Amitriptyline and Furazolidone (Letters) J. Amer. Med. Assoc. 213: 2080 (Sept. 21) 1970. (CH).

Amery A. Deloof W. : Cheese Reaction During Debrisoquine Treatment (Letter) Lancet 2: 613 (Sept. 19) 1970. (CH).

Aminu J. D'Mello A. Vere D. W. : Interactions between Debrisoquine and Phenylephrine (Letter) Lancet 2: 935 (Oct. 31) 1970. (CH).

Asatoor A. M. Levi A. J. Milne M. D. : Tranylcypromine and Cheese (Letter) Lancet 2: 733 (Oct. 5) 1963. (CHO).

Babiak W. : Case Fatality Due to Overdosage of a Combination of Tranylcypromine (Parnate) and Imipramine (Tofranil)., Can. Med. Assoc. J. 35: 377 (Aug. 12) 1961. (CH).

Beckett A. H. Rowland M. Turner P. : Influence of Urinary pH on Excretion of Amphetamines, Lancet 1: 303 (Feb. 6) 1965. (OH).

Bichel J. : Procarbazine and Cheese (Letter) Lancet 2: 877 (Oct. 19) 1968. (CH).

Blackwell B. : Tranylcypromine (Letter) Lancet 2: 414 (Aug. 24) 1963. (RCH).

Blackwell B. Marley E. : Interaction Between Cheese and Monoamine Oxidase Inhibitors in Rats and Cats, Lancet 1: 530 (Mar. 7) 1964. (OA).

Blackwell B. Marley E. Mabbitt L. A. : Effects of Yeast Extract after Monoamine Oxidase Inhibition, Lancet 1: 940 (May 1) 1965. (CHOA).

Blackwell B. Mabbitt L. A. : Tyramine in Cheese Related to Hypertensive Crises after Monoamine Oxidase Inhibition, Lancet 1: 938 (May 1) 1965. (OTH).

Blackwell B. : Hypertensive Interactions Between Monoamine Oxidase Inhibitors and Foodstuffs, Brit. J. Psychiat. 113: 349 (Apr.) 1967. (CHOR).

Blackwell B. Taylor D. C. : “Cold Cures” and Monoamine Oxidase Inhibitors, (Corresp.) Brit. Med. J. 2: 381 (May 10) 1969. (R).

Boismare F. : Interactions Between the Monoamine Oxidase Inhibitors and the Hypnotic Barbiturates. Hypothesis on the Mechanism of Action, Therapie 23: 863, 1968. (OA).

Boulton A. A. Cookson B. Paulton R. : Hypertensive Crisis in a Patient on MAOI Antidepressants Following a Meal of Beef Liver, Can. Med. Assoc. J. 102: 1394 (June 20) 1970. (CH).

Brachfeld J. Wirtshafter A. Wolfe S. : Imipramine — Tranylcypromine Incompatibility: Near-fatal Toxic Reaction, J. Amer. Med. Assoc. 186: 1172 (Dec. 28) 1963. (CH).

Brownlee G. Williams G. W. : Potentiation of Amphetamine and Pethidine by Monoamine Oxidase Inhibitors (Letters) Lancet 1: 669 (Mar. 23) 1963. (AO).

Burnett G. B. Reading H. W. : Drug Interactions in Alcoholism Treatment (Letters) Lancet 1: 415 (Feb. 22) 1969. (Comment).

Chang C. C. Costa E. Brodie B. B. : Interaction of Guanethidine with Adrenergic Neurons, J. Pharmacol. Exp. Therap. 147: 303 (Mar.) 1965. (OA).

Cheraskin E. : Caffeine versus Placebo Supplementation on Blood-Glucose Concentration, Lancet 1: 1299 (June 17) 1967. (OH).

Churchill-Davidson H. C. : Anaesthesia and Monoamine Oxidase Inhibitors (Letters) Brit. Med. J. 1: 520 (Feb. 20) 1965. (CHO).

Cocks D. P. Passmore-Rowe A. : Dangers of Monoamine Oxidase Inhibitors, Brit. Med. J. 2: 1545 (Dec. 8) 1962. (CH).

Cooper A. J. : The Action of Mebanazine, A Monoamine Oxidase Inhibitor Antidepressant Drug in Diabetes. Part II., Int. J. Neuropsychiat. 2: 342 (Aug.) 1966. (OCH).

Cooper A. J. Ashcroft G. : Potentiation of Insulin Hypoglycaemia by MAOI Antidepressant Drugs, Lancet 1: 407 (Feb. 19) 1966. (OA).

Cooper A. J. Ashcroft G. : Modification of Insulin and Sulfonylurea Hypoglycemia by Monoamine Oxidase Inhibitor Drugs, Diabetes 16: 272, (Apr.) 1967. (R).

Cotzias G. C. Papavasiliou P. S. Gellene R. : L-Dopa in Parkinson's Syndrome (Letters) N. Engl. J. Med. 281: 272 (July 31) 1969. (R).

Cuthbert M. F. Greenberg M. P. Morley S. W. : Cough and Cold Remedies: A Potential Danger to Patients on Monoamine Oxidase Inhibitors, Brit. Med. J. 1: 404 (Feb. 15) 1969. (CH).

Davies G. : Side-effects of Phenelzine, Brit. Med. J. 2: 1019 (Oct. 1) 1960. (CH).

Davies T. S. : Monoamine Oxidase Inhibitors and Rauwolfia Compounds, Brit. Med. J. 2: 739 (Sept. 3) 1960. (CH).

Davis J. M. : Overdosage of Psychotropic Drugs: A Review, Dis. Nerv. Syst. 29: 246 (Apr.) 1968. (R).

Day M. D. Rand M. J. : Antagonism of Guanethidine by Dexamphetamine and Other Related Sympathomimetic Amines, J. Pharm. Pharmacol. 14: 541 (Sept.) 1962. (OA).

Day M. D. Rand M. J. : Antagonism of Guanethidine and Bretylium by Various Agents, Lancet 2: 1282 (Dec. 15) 1962. (OA).

Deshmankar B. S. Lewis J. A. : Ventricular Tachycardia Associated with the Administration of Methylphenidate during Guanethidine Therapy, Can. Med. Assoc. J. 97: 1166 (Nov. 4) 1967. (CH).

Domino E. F. Sullivan T. S. Luby E. D. : Barbiturate Intoxication in a Patient Treated with a MAO Inhibitor, Amer. J. Psychiat. 118: 941 (Apr.) 1962. (CH).

Done A. K. : Developmental Pharmacology, Clin. Pharmacol. Ther. 5: 432 (July-Aug.) 1964. (R).

Eade N. R. Renton K. W. : Effect of Monoamine Oxidase Inhibitors on the N-demethylation and Hydrolysis of Meperidine, Biochem. Pharmacol. 19: 2243 (July) 1970. (OA).

Eble J. N. Rudzik A. D. : Tyramine and Amphetamine (Letter) Lancet 1: 766 (Apr. 2) 1966. (OA).

Eble J. N. Rudzik A. D. : Amphetamine: Augmentation of Pressor Effects of Tyramine in Rats, Proc. Soc. Exp. Biol. Med. 122: 1059 (Aug.-Sept.) 1966. (OA).

Elis J. : Modification by Monoamine Oxidase Inhibitors of the Effect of Some Sympathomimetics on Blood Pressure, Brit. Med. J. 2: 75 (Apr. 8) 1967. (OH).

Gander D. R. : Treatment of Depressive Illnesses with Combined Antidepressants, Lancet 2: 107 (July 17) 1973. (RCH).

Garrettson L. K. Perel J. M. Dayton P. G. : Methylphenidate Interaction with both Anticonvulsants and Ethyl biscoumacetate, J. Amer. Med. Assoc. 207: 2053 (Mar. 17) 1969. (CHO).

Gelder M. G. Vane J. R. : Interaction of the Effects of Tyramine, Amphetamine and Reserpine in Man, Psychopharmacol. 3: 231, 1962. (OH).

Glazener F. S. : Pargyline, Cheese, and Acute Hypertension, J. Amer. Med. Assoc., 188: 754 (May 25) 1964. (CH).

Gokhale S. D. Gulati O. D. Udwadia B. P. : Antagonism of the Adrenergic Neurone Blocking Action of Guanethidine by Certain Antidepressant and Antihistamine Drugs, Arch. Int. Pharmacodyn. 160: 321 (Apr.) 1966. (OA).

Goldberg L. J. : Monoamine Oxidase Inhibitors, Adverse Reactions and Possible Mechanisms, J. Amer. Med. Assoc. 190: 456 (Nov. 2) 1964. (R).

Goodman L. S. Gilman A. : The Pharmacological Basis of Therapeutics, New York, The MacMillan Company, 1970, Fourth Edition. (R).

Gram L. F. : Imipramine Metabolism: Ph-dependent Distribution and Urinary Excretion, Clin. Pharmacol. Ther. 12: 239 (Mar.-Apr.) 1971. (OHA).

Gram L. F. Overo K. F. : Drug Metabolism: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in Man, Brit. Med. J. 1: 463 (Feb. 19) 1972. (OH).

Gulati O. D. : Antagonism of Adrenergic Neuron Blockade in Hypertensive Subjects, Clin. Pharmacol. Therap. 7: 510 (July-Aug.) 1966. (OH).

Hague D. E. : Effect of Methylphenidate and Prolintane on the Metabolism of Ethyl Biscoumacetate, Clin. Pharmacol. Ther. 12: 259 (Mar.-Apr.) 1971. (OH).

Hammer W. Martens S. Sjoqvist F. : A Comparative Study of the Metabolism of Desmethylimipramine, Nortriptyline, and Oxyphenylbutazone in Man, Clin. Pharmacol. Ther. 10: 44 (Jan.-Feb.) 1969. (OH).

Hedberg D. L. Gordon M. W. Glueck B. C. : Six Cases of Hypertensive Crisis in Patients on Tranylcypromine after Eating Chicken Liver, Amer. J. Psychiat. 122: 933 (Feb.) 1966. (CH).

Hirsch M. S. Walter R. M. Hasterlik R. J. : Subarachnoid Hemorrhage Following Ephedrine and MAO Inhibitors (Letters) J. Amer. Med. Assoc. 194: 1259 (Dec. 13) 1965. (CH).

Hodge J. V. Nye E. R. Emerson G. W. : Monoamine Oxidase Inhibitors, Broad Beans, and Hypertension. (Letters) Lancet 1: 1108 (May 16) 1964. (CHOA).

Horler A. R. Wynne N. A. : Hypertensive Crisis Due to Pargyline and Metaraminol, Brit. Med. J. 2: 460 (Aug. 21) 1965. (CH).

Horwitz D. : Monoamine Oxidase Inhibitors, Tyramine, and Cheese, J. Amer. Med. Assoc. 188: 1108 (Jan. 29) 1964. (OH).

Hrdina P. Garattini S. : Desipramine and Potentiation of Noradrenaline in the Isolated Perfused Renal Artery (Letter) J. Pharm. Pharmacol. 18: 259 (Apr.) 1966. (OT).

Hunter K. R. : Monoamine Oxidase Inhibitors and L-Dopa, Brit. Med. J. 3: 388 (Aug. 15) 1970. (OHC).

Jarecki H. G. : Combined Amitriptyline and Phenelzine Poisoning, Amer. J. Psychiat. 120: 189 (Aug.) 1963. (CH).

Jenkins L. C. Graves H. B. : Potential Hazards of Psychoactive Drugs in Association with Anesthesia, Can. Anaesth. Soc. J. 12: 121 (Mar.) 1965. (RCH).

Jori A. Garattini S. : Interaction Between Imipramine-like Agents and Catecholamine-Induced Hyperthermia, J. Pharm. Pharmacol. 17: 480 (Aug.) 1965. (OA).

Jori A. Carrara M. C. Garattini S. : Importance of Noradrenaline Synthesis for the Interaction between Desipramine and Reserpine (Letter) J. Pharm. Pharmacol. 18: 619 (Sept.) 1966. (OA).

Kane F. J. Taylor T. W. : A Toxic Reaction to Combined Elavil-Librium Therapy, Amer. J. Psychiat. 119: 1179 (June) 1963. (CH).

Kaumann A. Basso N. Aramendia P. : The Cardiovascular Effects of N — (α — Methylaminopropyl-iminodibenzyl)-HCl (Desmethylimipramine) and Guanethidine, J. Pharmacol. Exp. Ther. 147: 54 (Jan.) 1965. (OAT).

Kramp J. L. : Glutamic Pyruvic Acid Transaminases during Treatment with Amitriptyline and Imipramine, Acta Psychiat. Scand. 43: 1, 1967. (OH).

Krisko I. Lewis E. Johnson J. E. III : Severe Hyperpyrexia Due to Tranylcypromine-Amphetamine Toxicity, Ann. Intern. Med. 70: 559 (Mar.) 1969. (CH).

Kupferberg H. J. Jeffery W. Hunninghake D. B. : Effect of Methylphenidate on Plasma Anticonvulsant Levels, Clin. Pharmacol. Ther. 13: 201 (Mar.-Apr.) 1971. (OH).

Landauer A. A. Milner G. Patman J. : Alcohol and Amitriptyline Effects on Skills Related to Driving Behavior, Science 163: 1467 (Mar. 28) 1969. (OH).

Lechat P. Fontagne J. Giroud J. : Influence of a Previous Administration of Tricyclic Antidepressant Compounds on the Activity of Local Anesthetics, Therapie 24: 393 (May-June) 1969. (OA).

Leishman A. W. D. Matthews H. L. Smith A. J. : Antagonism of Guanethidine by Imipramine (Letters) Lancet 1: 112 (Jan. 12) 1963. (CH).

Leonard J. W. Gifford R. W. Jr. Williams G. H. Jr. : Pargyline and Cheese, Lancet 1: 883 (Apr. 18) 1964. (CH).

Lloyd J. T. A. Walker D. R. H. : Death after Combined Dexamphetamine and Phenelzine (Letter) Brit. Med. J. 2: 168 (July 17) 1965. (CH).

Lockett M. F. Milner G. : Combining the Antidepressant Drugs (Letter) Brit. Med. J. 1: 921 (Apr. 3) 1965. (CHOA).

Luby E. D. Domino E. F. : Toxicity from Large Doses of Imipramine and an MAO Inhibitor in Suicidal Intent, J. Amer. Med. Assoc. 177: 68 (July 8) 1961. (CHAO).

MacCallum W. A. G. : Drug Interactions in Alcoholism Treatment (Letter) Lancet 1: 313 (Feb. 8) 1969. (H).

Mason A. M. S. Buckle R. M. : “Cold” cures and Monoamine-oxidase Inhibitors, Brit. Med. J. 1: 845 (Mar. 29) 1969. (CH).

McCurdy R. L. Kane F. J. : Transient Brain Syndrome as a Non-fatal Reaction to Combined Pargyline-Imipramine Treatment, Amer. J. Psychiat. 121: 397 (Oct.) 1964. (CH).

Meyer J. F. McAllister C. K. Goldberg L. I. : Insidious and Prolonged Antagonism of Guanethidine by Amitriptyline, J. Amer. Med. Assoc. 213: 1487 (Aug. 31) 1970. (CH).

Milner G. : Cumulative Lethal Dose of Alcohol in Mice Given Amitriptyline, J. Pharm. Sci. 57: 2005 (Nov.) 1968. (OA).

Mirkin B. L. Wright F. , Drug Interactions: Effect of Methylphenidate on the Disposition of Diphenylhydantoin in Man, Neurol. 21: 1123 (Nov.) 1971. (OH).

Misage J. R. McDonald R. H. : Antagonism of Hypotensive Action of Bethanidine by “Common Cold” Remedy, Brit. Med. J. 4: 347 (Nov. 7) 1970. (CH).

Mitchell J. R. Arias L. Oates J. A. : Antagonism of the Antihypertensive Action of Guanethidine Sulfate by Desipramine Hydrochloride, J. Amer. Med. Assoc. 202: 973 (Dec. 4) 1967. (OH).

Mitchell J. R. : Guanethidine and Related Agents. III. Antagonism by Drugs which Inhibit the Norepinephrine Pump in Man, J. Clin. Invest. 49: 1596 (Aug.) 1970. (OH).

Mond E. Mack I. : Cardiac Toxicity of Iproniazid (Marsilid): Report of Myocardial Injury in a Patient Receiving Levarterenol, Amer. Heart J. 59: 134 (Jan.) 1960. (CH).

Natarjan S. : Potential Danger of Monoamine Oxidase Inhibitors and α-methyldopa (Letter) Lancet 1: 1330 (June 13) 1964. (Comment).

Natoff I. L. : Cheese and Monoamine Oxidase Inhibitors. Interaction in Anaesthetised Cats, Lancet 1: 532 (Mar. 7) 1964. (OA).

Nuessle W. F. Norman F. C. Miller H. E. : Pickled Herring and Tranylcypromine Reaction (Letter) J. Amer. Med. Assoc. 192: 726 (May 24) 1965. (CH).

Reilly M. J. , (Ed): American Hospital Formulary Service, American Society of Hospital Pharmacists, Washington, D.C.

Palmer H. : Potentiation of Pethidine, Brit. Med. J. 2: 944 (Sept. 24) 1960. (CH).

Papp C. Beniam S. : Toxic Effects of Iproniazid in a Patient with Angina, Brit. Med. J. 2: 1070 (Nov. 1) 1958. (CH).

Parker W. J. : Alcohol-Drug Interactions, J. Amer. Pharm. Assoc. NS10: 664 (Dec.) 1970. (R).

Paykel E. S. : Hallucinosis on Combined Methyldopa and Pargyline (Corresp.) Brit. Med. J. 1: 803 (Mar. 26) 1966. (CH).

Penlington G. N. : Droperidol and Monoamine Oxidase Inhibitors (Letter) Brit. Med. J. 1: 483 (Feb. 19) 1966. (CH).

Pettinger W. A. Soyangco F. G. Oates J. A. : Monoamine Oxidase Inhibition by Furazolidone in Man, Clin. Res. 14: 258 (Apr.) 1966 (Abstract). (OHA).

Pettinger W. A. Soyangco F. G. Oates J. A. : Inhibition of Monoamine Oxidase in Man by Furazolidone, Clin. Pharmacol. Ther. 9: 442 (July-Aug.) 1968. (OH).

Prange A. J. Jr. : Enhancement of Imipramine Antidepressant Activity by Thyroid Hormone, Amer. J. Psychiat. 126: 457 (Oct.) 1969. (OH).

Rivers N. Horner B. : Possible Lethal Reaction Between Nardil and Dextromethorphan (Corresp.) Can. Med. Assoc. J. 103: 85 (July 4) 1970. (CH).

Sargent W. : Combining the Antidepressant Drugs (Letter) Brit. Med. J. 1: 251 (Jan. 23) 1965. (Comment).

Schiff D. Chan G. Stern L. : Fixed Drug Combinations and Displacement of Bilirubin from Albumin, Pediatrics 48: 139 (July) 1971. (OT).

Schildkraut J. J. : Biochemical and Pressor Effects of Oral D,L-Dihydroxyphenylalanine in Patients Pretreated with Antidepressant Drugs, Ann. N.Y. Acad. Sci. 107: 1005 (July 8) 1963. (OH).

Shamsie S. J. Barriga G. : The Hazards of Use of Monoamine Oxidase Inhibitors in Disturbed Adolescents, Can. Med. Assoc. J. 104: 715 (Apr. 17) 1971. (CH).

Shee J. C. : Dangerous Potentiation of Pethidine by Iproniazid, and its Treatment, Brit. Med. J. 2: 507 (Aug. 13) 1960. (CH).

Sjoqvist F. : Psychotropic Drugs (2) Interaction Between Monoamine Oxidase (MAO) Inhibitors and Other Substances, Proc. Roy. Soc. Med. 58: 967 (Nov.) 1965 (R).

Skinner C. Coull D. C. Johnston A. W. : Antagonism of Hypotensive Action of Bethanidine and Debrisoquine by Tricyclic Antidepressants, Lancet 2: 564 (Sept. 13) 1969 (CH).

Soucek K. Plzak M. : Diuretics in the Therapy of Affective Psychosis, Activitas Nervosa Super. 9: 388, 1967.

Stone C. A. : Antagonism of Certain Effects of Catecholamine-depleting Agents by Antidepressant and Related Drugs, J. Pharmacol. Exp. Ther. 144: 196 (May) 1964. (OA).

Svedmyr N. : Potentiation Risks in the Administration of Catecholamines to Patients Treated with Tricyclic Antidepressive Agents, Svenska Lakartidn 65: 72 (Supp. 1) 1968.

Tonks C. M. Lloyd A. T. : Hazards with Monoamine Oxidase Inhibitors, Brit. Med. J. 1: 589 (Feb. 27) 1965. (CH).

Trevelyan M. R. : Monoamine Oxidase Inhibitors (Letter) Brit. Dent. J. 128: 263 (Mar. 17) 1970. (RCH).

Turner P. : Influence of Urinary pH on the Excretion of Tranylcypromine Sulphate, Nature 215: 881 (Aug. 19) 1967. (OH).

Van Rossum J. M. : Potential Danger of Monoamine Oxidase Inhibitors and α-methyldopa, Lancet 1: 950 (Apr. 27) 1963. (OA).

Vessell E. S. Passananti G. T. Greene F. E. : Impairment of Drug Metabolism in Man by Allopurinol and Nortriptyline, N. Engl. J. Med. 283: 1484 (Dec. 31) 1970. (OH).

Vigran I. M. : Potentiation of Meperidine Hydrochloride by Pargyline Hydrochloride, J. Amer. Med. Assoc. 187: 953 (Mar. 21) 1964. (CH).

Warnes H. Lehmann H. E. Ban T. A. : Adynamic Ileus During Psychoactive Medication: A Report of Three Fatal and Five Severe Cases., Can. Med. Assoc. J. 96: 1112 (Apr. 15) 1967. (CH).

Wharton R. N. : Potential Clinical Use for Methylphenidate with Tricyclic Antidepressants, Amer. J. Psychiat. 127: 1619 (June) 1971. (CH).

White A. G. : Methyldopa and Amitriptyline (Letter) Lancet 2: 441 (Aug. 28) 1965. (CH).

Wickstrom L. Pettersson K. : Treatment of Diabetics with Monoamine Oxidase Inhibitors, Lancet 2: 995 (Nov. 7) 1964. (OH).

Williams R. B. Sherter C. : Cardiac Complications of Tricyclic Antidepressant Therapy, Ann. Intern. Med. 74: 395 (Mar.) 1971. (CH).

Wilson I. C. : Thyroid-hormone Enhancement of Imipramine in Non-retarded Depressions, N. Engl. J. Med. 282: 1063 (May 7) 1970. (OH).

Wilson L. : The Combined Effects of Ethanol and Amphetamine Sulfate on Performance of Human Subjects, Can. Med. Assoc. J., 94: 478 (Mar. 5) 1966. (OH).

Wilson R. Long C. : Action of Bretylium Antagonized by Amphetamine (Letter) Lancet 2: 262 (July 30) 1960. (OH).

Winer J. A. Bahn S. : Loss of Teeth with Antidepressant Drug Therapy, Arch. Gen. Psychiat. 16: 239 (Feb.) 1967. (CH).

Witton K. : Severe Toxic Reaction to Combined Amitriptyline and Thioridazine, Amer. J. Psychiat. 121: 812 (Feb.) 1965. (CH).